Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

PIERRE FABRE MEDICAMENT PORTUGAL, LDA

NIF 500230366
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €2,101,093 40 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €2,101,093 40 contracts
A2 · Late Publication €3,122,223,646 790 contracts
Contract published to BASE more than 10 days after the signing date
LOW €3,122,223,646 790 contracts
A5 · Threshold Splitting €1,335,878 29 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €1,335,878 29 contracts
A6 · Low Competition €1,822,657 8 contracts
Only one bidder participated in a competitive procedure
MEDIUM €1,822,657 8 contracts
A9 · Abnormal Price Reduction €3,993,690,158 363 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €3,993,690,158 363 contracts
C3 · Missing Mandatory Fields €2,987,582 31 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €2,987,582 31 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

83
€405,303,557
189
€242,900,270
62
€242,436,150
58
€204,630,624
16
€196,781,618
18
€196,322,445
42
€196,247,655
16
€186,890,400
36
€185,566,390
14
€177,986,050
18
€177,181,390
12
€175,708,598
43
€173,100,386
25
€166,432,188
7
€154,699,539
6
€151,555,263
8
€147,740,535
8
€83,812,071
33
€79,992,947
42
€63,474,989
Page 1 of 3 · 52 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 1 · 29 contracts

Aquisição de ENCORAFENIB 75MG CAPS (AQ 2023-491) SPMS
PT · 11641513 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€147,005 2025-05-29
Q1/4030/2024 – MEDICAMENTOS DO FORO ONCOLÓGICO E IMUNOMODULADORES
PT · 11257329 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€71,684 2025-01-08
VÁRIOS MEDICAMENTOS
PT · 10962746 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€74,243 2024-10-08
ENCORAFENIB 75 MG CAPSULA
PT · 10158787 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,600 2023-02-13
2023010004 - ENCORAFENIB 75MG
PT · 9823178 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,600 2023-01-03
PC2022100068 - ENCORAFENIB
PT · 9524228 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,600 2022-10-17
PC2022100068 - ENCORAFENIB
PT · f255a4e6789e2f0684bc · Ajuste Direto Regime G...
A2 · Late Publication A5 · Threshold Splitting
€19,600 2022-10-17
2022080040 - ENCORAFENIB 75MG
PT · 9423584 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,600 2022-08-11
2022080040 - ENCORAFENIB 75MG
PT · 06ae8bb64d8fc035a30e · Ajuste Direto Regime G...
A2 · Late Publication A5 · Threshold Splitting
€19,600 2022-08-11
PC2022040028 - ENCORAFENIB 75MG
PT · 9193181 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,600 2022-04-08
PC2022040028 - ENCORAFENIB 75MG
PT · a5608972edef53584377 · Ajuste Direto Regime G...
A2 · Late Publication A5 · Threshold Splitting
€19,600 2022-04-08
Aquisição dos medicamentos Ecorafenib 75mg caps e Binimetinib 15mg com, para o ano 2022
PT · 649def77581b05598d31 · Ajuste Direto Regime G...
A2 · Late Publication A5 · Threshold Splitting
€147,502 2022-01-19
Aquisição dos Medicamentos ENCORAFENIB 75 MG CÁPS e BINIMETINIB 15 MG COMP, para doentes especificos
PT · 8399230 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€74,462 2021-11-11
BINIMETINIB 15 MG COMP E ENCORAFENIB 75 MG CÁPS
PT · 7722481 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€73,899 2021-06-16
Aquisição de Medicamentos Diversos - SPMS 2019/61 - Ano 2020
PT · 7302069 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€74,417 2020-11-20
MEDICAMENTOS
PT · 6324288 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€19,200 2020-01-24
MEDICAMENTOS
PT · 5503926 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€4,812 2019-02-21
61004719-AQ. Urgente-Vários Medicamentos
PT · 5903153 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€19,521 2019-01-10
Q1/13/2018 Agregação urgente - diversos - maio
PT · 2fc37f9fb2f3ce620654 · Ao abrigo de acordo-qu...
A2 · Late Publication A5 · Threshold Splitting
€4,946 2018-04-30
Q1/13/2018 MEDICAMENTOS DIVERSOS
PT · 4467141 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€145,227 2018-03-07
P259-AC-2017-148_AQUISIÇÃO DE MEDICAMENTOS DESENCADEADA PELA SPMS, EPE NO ÂMBITO DO DESPACHO 1571/B DE 2016 AO ABRIGO DO ACORDO QUADRO 2017/61 Aquisição de Medicamentos Diversos
PT · 4100451 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€4,954 2018-01-01
P259-AC-2017-148 Aquisição Centralizada pela SPMS-Medicamentos Vinorrelbina ano 2018
PT · 4408208 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€73,204 2017-11-21
Aquisição de medicamentos diversos
PT · 4219616 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€71,337 2017-11-21
51001417 - P259-AC-2017-06, AQUISIÇÃO DE MEDICAMENTOS DESENCADEADA PELA SPMS,EPE NO ÂMBITO DO DESPACHO N. 1571-B 2016; Vinorrelbina
PT · 3384571 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,996 2017-02-23
51001417 - P259-AC-2017-06, AQUISIÇÃO DE MEDICAMENTOS DESENCADEADA PELA SPMS,EPE NO ÂMBITO DO DESPACHO N. 1571-B 2016; Vinorrelbina
PT · 0a5507a420de0e31c796 · Ao abrigo de acordo-qu...
A2 · Late Publication A5 · Threshold Splitting
€19,996 2017-02-23
Concurso Centralizado SPMS Vinorelbina 20mg e 30 mg caps
PT · 4053364 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€73,060 2017-02-21
Aquisição de Vinorrelbina
PT · 1490521 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€19,870 2015-06-29
AD para Aquisição de Vinorrelbina (Várias Dosagens)
PT · 1674242 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,870 2015-04-24
Vários Medicamentos Pierre Fabre
PT · 1510065 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,870 2015-01-13
Overview
Total Value Won
€4,038,198,125
Contracts Won
1,067
Score 39025 · CRITICAL RISK
NIF
500230366
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • E.Y. [P-6b36]
    Gerente
    since 2010-10-14
  • J.C. [P-68bf]
    Gerente
    since 2010-10-14
  • S.M. [P-0e6d]
    Gerente
    since 2026-03-05
  • A.H. [P-4994]
    Gerente
    until 2010-10-14
  • B.A. [P-d983]
    Gerente
    2010-10-14 → 2026-03-05
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned